1. Home
  2. CLF vs RYTM Comparison

CLF vs RYTM Comparison

Compare CLF & RYTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cleveland-Cliffs Inc.

CLF

Cleveland-Cliffs Inc.

N/A

Current Price

$10.67

Market Cap

7.5B

ML Signal

N/A

Logo Rhythm Pharmaceuticals Inc.

RYTM

Rhythm Pharmaceuticals Inc.

N/A

Current Price

$112.34

Market Cap

6.3B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CLF
RYTM
Founded
1847
2008
Country
United States
United States
Employees
25000
N/A
Industry
Metal Mining
Biotechnology: Pharmaceutical Preparations
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.5B
6.3B
IPO Year
2006
2017

Fundamental Metrics

Financial Performance
Metric
CLF
RYTM
Price
$10.67
$112.34
Analyst Decision
Hold
Strong Buy
Analyst Count
13
19
Target Price
$14.75
★ $139.76
AVG Volume (30 Days)
★ 17.3M
1.8M
Earning Date
10-19-2026
11-03-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 28.34
EPS
★ N/A
N/A
Revenue
★ $18,610,000,000.00
N/A
Revenue This Year
$15.06
$74.20
Revenue Next Year
$8.86
$74.91
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$7.73
$74.50
52 Week High
$15.35
$122.20

Technical Indicators

Market Signals
Indicator
CLF
RYTM
Relative Strength Index (RSI) 34.75 57.34
Support Level $10.56 $100.33
Resistance Level $11.27 $113.31
Average True Range (ATR) 0.81 8.32
MACD -0.24 0.87
Stochastic Oscillator 0.13 78.21

Price Performance

Historical Comparison
CLF
RYTM

About CLF Cleveland-Cliffs Inc.

Cleveland-Cliffs Inc is a flat-rolled steel producer and manufacturer of iron ore pellets in North America. It is organized into four operating segments based on differentiated products, Steelmaking, Tubular, Tooling and Stamping and European Operations, but operates through one reportable segment -Steelmaking. It is vertically integrated from mined raw materials, direct reduced iron, and ferrous scrap to primary steelmaking and downstream finishing, stamping, tooling and tubing. It serves a diverse range of other markets due to its comprehensive offering of flat-rolled steel products. Geographically, it operates in the United States, Canada and other countries. The majority of revenue is from the United States. It is a supplier of steel to the automotive industry in North America.

About RYTM Rhythm Pharmaceuticals Inc.

Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company engaged in the development and commercialization of therapies for patients with rare neuroendocrine diseases. The company is focused on advancing its melanocortin-4 receptor (MC4R) agonists, including its main asset, IMCIVREE (setmelanotide), as a precision medicine designed to treat hyperphagia and severe obesity caused by rare MC4R pathway diseases. In addition, it has two early-stage investigational MC4R agonists in clinical development, RM-718 and bivamelagon, designed not to cause hyperpigmentation. The company is also focused on advancing potential candidates for congenital hyperinsulinism. It currently operates in two business segments: the United States, which generates maximum revenue, and International.

Share on Social Networks: